Detalhe da pesquisa
1.
Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial.
Catheter Cardiovasc Interv
; 102(3): 464-471, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493431
2.
Optical coherence tomography assessment of acute thrombogenicity at bifurcation sites using different stenting techniques: A porcine arteriovenous shunt study.
Catheter Cardiovasc Interv
; 99(7): 1998-2005, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35485729
3.
Paclitaxel-related balloons and stents for the treatment of peripheral artery disease: Insights from the Food and Drug Administration 2019 Circulatory System Devices Panel Meeting on late mortality.
Am Heart J
; 222: 112-120, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32028137
4.
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.
Lancet
; 390(10105): 1843-1852, 2017 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28851504
5.
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial.
Lancet
; 387(10013): 31-9, 2016 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26470647
6.
Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.
Eur Heart J
; 37(3): 229-40, 2016 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26405232
7.
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.
Lancet
; 385(9962): 43-54, 2015 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25230593
8.
Comparison of endothelial shear stress between ultrathin strut bioresorbable polymer drug-eluting stent vs durable-polymer drug-eluting stent post-stent implantation: An optical coherence tomography substudy from BIOFLOW II.
Cardiovasc Revasc Med
; 61: 26-34, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38042738
9.
Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease.
Int J Mol Sci
; 14(12): 24492-500, 2013 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24351829
10.
Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments.
Circ J
; 76(7): 1616-23, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22531596
11.
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.
Eur Heart J
; 32(3): 294-304, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21123276
12.
Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial.
Eur Heart J
; 32(19): 2454-63, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21659439
13.
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes.
JACC Cardiovasc Interv
; 15(18): 1852-1860, 2022 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36137689
14.
Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials.
Clin Res Cardiol
; 111(7): 795-805, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35212802
15.
A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE).
EuroIntervention
; 18(2): e132-e139, 2022 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794936
16.
Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial.
Circulation
; 122(22): 2288-300, 2010 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20975003
17.
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
Circulation
; 122(22): 2301-12, 2010 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21098436
18.
Long-term tissue coverage of a biodegradable polylactide polymer-coated biolimus-eluting stent: comparative sequential assessment with optical coherence tomography until complete resorption of the polymer.
Am Heart J
; 162(5): 922-31, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22093210
19.
Second-Generation Drug-Eluting Resorbable Magnesium Scaffold: Review of the Clinical Evidence.
Cardiovasc Revasc Med
; 21(1): 127-136, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31662277
20.
Automated lumen segmentation using multi-frame convolutional neural networks in intravascular ultrasound datasets.
Eur Heart J Digit Health
; 1(1): 75-82, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36713961